Pam M. Van Ry

822 total citations
19 papers, 533 citations indexed

About

Pam M. Van Ry is a scholar working on Molecular Biology, Biomedical Engineering and Surgery. According to data from OpenAlex, Pam M. Van Ry has authored 19 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Biomedical Engineering and 5 papers in Surgery. Recurrent topics in Pam M. Van Ry's work include Muscle Physiology and Disorders (7 papers), 3D Printing in Biomedical Research (5 papers) and Galectins and Cancer Biology (5 papers). Pam M. Van Ry is often cited by papers focused on Muscle Physiology and Disorders (7 papers), 3D Printing in Biomedical Research (5 papers) and Galectins and Cancer Biology (5 papers). Pam M. Van Ry collaborates with scholars based in United States, Portugal and Switzerland. Pam M. Van Ry's co-authors include Jonard Corpuz Valdoz, Dean J. Burkin, Gregory P. Nordin, Ken Christensen, Bradley L. Hodges, Benjamin C. Johnson, Adam T. Woolley, Alonzo D. Cook, Ryan D. Wuebbles and Connie M. Arthur and has published in prestigious journals such as Nature Communications, PLoS ONE and Analytical Chemistry.

In The Last Decade

Pam M. Van Ry

18 papers receiving 526 citations

Peers

Pam M. Van Ry

IMMUN

SURGE

Helen Harrington United Kingdom

Corinne A. Hoesli Canada

Sohyung Lee United States

Dominik Egger Austria

Meixiang Xiang China

Hsin-Hsin Shen Taiwan

Uta Fernekorn Germany

Ting‐Yuan Tu Taiwan

Erik Vrij Netherlands

Yu Xiong China

Helen Harrington United Kingdom

Pam M. Van Ry

349 ×1.5

97 ×0.5

40 ×0.4

42 ×0.6

IMMUN

74 ×1.2

SURGE

Citations per year, relative to Pam M. Van Ry Pam M. Van Ry (= 1×) peers Helen Harrington

Countries citing papers authored by Pam M. Van Ry

Since Specialization

Citations

This map shows the geographic impact of Pam M. Van Ry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pam M. Van Ry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pam M. Van Ry more than expected).

Fields of papers citing papers by Pam M. Van Ry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pam M. Van Ry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pam M. Van Ry. The network helps show where Pam M. Van Ry may publish in the future.

Co-authorship network of co-authors of Pam M. Van Ry

This figure shows the co-authorship network connecting the top 25 collaborators of Pam M. Van Ry. A scholar is included among the top collaborators of Pam M. Van Ry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pam M. Van Ry. Pam M. Van Ry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ray, Jason D., et al.. (2024). CEBPA Overexpression Enhances β-Cell Proliferation and Survival. Biology. 13(2). 110–110. 5 indexed citations

Woolley, Adam T., et al.. (2024). Integrated biocompatible 3D printed isoporous membranes with 7 μm pores. Lab on a Chip. 24(8). 2202–2207. 6 indexed citations

Ry, Pam M. Van, et al.. (2023). Idiopathic pulmonary fibrosis: aligning murine models to clinical trials in humans. The Lancet Respiratory Medicine. 11(11). 953–955. 4 indexed citations

Liang, Yiran, Thy Truong, Hannah Boekweg, et al.. (2023). HyperSCP: Combining Isotopic and Isobaric Labeling for Higher Throughput Single-Cell Proteomics. Analytical Chemistry. 95(20). 8020–8027. 19 indexed citations

Arthur, Connie M., et al.. (2022). Evaluating Therapeutic Activity of Galectin-1 in Sarcolemma Repair of Skeletal Muscle. Methods in molecular biology. 2442. 663–683. 1 indexed citations

Davis, Gregg S., et al.. (2022). RAGE signaling during tobacco smoke-induced lung inflammation and potential therapeutic utility of SAGEs. BMC Pulmonary Medicine. 22(1). 160–160. 8 indexed citations

Valdoz, Jonard Corpuz, et al.. (2021). Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B. Cells. 10(11). 3210–3210. 3 indexed citations

Valdoz, Jonard Corpuz, et al.. (2021). Spatially and optically tailored 3D printing for highly miniaturized and integrated microfluidics. Nature Communications. 12(1). 5509–5509. 113 indexed citations

Valdoz, Jonard Corpuz, et al.. (2021). The ECM: To Scaffold, or Not to Scaffold, That Is the Question. International Journal of Molecular Sciences. 22(23). 12690–12690. 89 indexed citations

10.

Valdoz, Jonard Corpuz, et al.. (2021). An Improved Scalable Hydrogel Dish for Spheroid Culture. Life. 11(6). 517–517. 8 indexed citations

11.

Valdoz, Jonard Corpuz, et al.. (2020). Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models. PLoS ONE. 15(9). e0238441–e0238441. 15 indexed citations

12.

Valdoz, Jonard Corpuz, et al.. (2020). Biocompatible PEGDA Resin for 3D Printing. ACS Applied Bio Materials. 3(4). 2239–2244. 98 indexed citations

13.

Robinson, Brian, Connie M. Arthur, Nourine A. Kamili, et al.. (2019). The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function. Frontiers in Immunology. 10. 1762–1762. 45 indexed citations

14.

Willmann, Raffaella, Heather Gordish‐Dressman, Sarina Meinen, et al.. (2017). Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy. Journal of Neuromuscular Diseases. 4(2). 115–126. 10 indexed citations

15.

Ry, Pam M. Van, et al.. (2017). ECM‐Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies. Comprehensive physiology. 7(4). 1519–1536. 12 indexed citations

16.

Ry, Pam M. Van, et al.. (2017). Evaluation of the behavioral characteristics of the mdx mouse model of duchenne muscular dystrophy through operant conditioning procedures. Behavioural Processes. 142. 8–20. 10 indexed citations

17.

Ry, Pam M. Van, et al.. (2017). ECM‐Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies. Comprehensive physiology. 7(4). 1519–1536.

18.

Ry, Pam M. Van, et al.. (2015). Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy. Molecular Therapy. 23(8). 1285–1297. 32 indexed citations

19.

Ry, Pam M. Van, et al.. (2013). Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy. Human Molecular Genetics. 23(2). 383–396. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact